maybe reading the whole announcement will give you a better understanding.
mutually agreed deliverables that "upon execution" will result in a commercial agreement. I don't read that as having a road map !!!
then we have "Why ramp up production without an agreement in place?"
we need to prove that we can supply anteoX at volume with quality assurance before any company would sign a commercial deal. which both are stated will happen this quarter.
and finally with the missed June Kpi about anteobind distribution, we have added Biogenuix (india ) to our website distributors so I disagree that was missed !!!
but as I have said before, each to their own opinion.
ADO Charting and Technical Analysis, page-7917
-
- There are more pages in this discussion • 1,322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $6.441K | 307.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2155694 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 588561 | 1 |
View Market Depth
| Last trade - 11.33am 24/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |